Condition
Mastectomy and Breast Reconstruction
Total Trials
6
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Not Yet Recruiting3
Terminated1
Recruiting1
Active Not Recruiting1
Clinical Trials (6)
Showing 6 of 6 trials
NCT06627582Not ApplicableActive Not Recruiting
A Study on Pain After Breast Reconstruction
NCT07434648Not ApplicableNot Yet RecruitingPrimary
Comparison of Mastectomy Expander Trial
NCT07234461Not ApplicableRecruitingPrimary
Sexual Well-being of Women Undergoing Mastectomy and Reconstruction
NCT07308275Not ApplicableNot Yet Recruiting
Longitudinal Evaluation of Direct Neurotization Technique in Breast Reconstruction With Fully Autologous Components
NCT06956443Not Yet Recruiting
Prediction of ICG for Skin Necrosis in Mastectomy With Immediate Reconstruction
NCT01910298Not ApplicableTerminatedPrimary
Efficacy Study of Single Stage Breast Reconstruction in Female Participants With Mastectomy
Showing all 6 trials